Differential anti-neuropathic pain effects of tetrodotoxin in sciatic nerve- versus infraorbital nerve-ligated rats - Behavioral, pharmacological and immunohistochemical investigations

Neuropharmacology

Volumn 58, Issue 2, 2010, Pages 474-487

  Kayser, Valérie ^a,b   Viguier, Florent ^a,b   Ioannidi, Myrto ^a,b   Bernard, Jean François ^a,b   Latrémolière, Alban ^a,b   Michot, Benoît ^a,b   Vela, José Miguel ^c   Buschmann, Helmut ^c   Hamon, Michel ^a,b   Bourgoin, Sylvie ^a,b  

^a INSERM   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c Laboratorios Dr Esteve SA   (Spain)

Author keywords

c Fos immunostaining; Monoaminergic and opioidergic receptors; Neuropathic pain; Sodium channels; Tetrodotoxin

Indexed keywords

IDAZOXAN; MORPHINE; NALOXONE; PROTEIN C FOS; TETRODOTOXIN;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; HEART RATE; HYPERALGESIA; IMMUNOHISTOCHEMISTRY; INFRAORBITAL NERVE; LUMBAR SPINAL CORD; MALE; MECHANICAL STIMULATION; MOTOR COORDINATION; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PAIN THRESHOLD; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SCIATIC NERVE; SPINAL CORD DORSAL HORN;

ANESTHETICS, LOCAL; ANIMALS; CHRONIC DISEASE; CRANIAL NERVE DISEASES; DRUG THERAPY, COMBINATION; HYPERALGESIA; IMMUNOHISTOCHEMISTRY; LUMBAR VERTEBRAE; MALE; NEURALGIA; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; SCIATIC NEUROPATHY; SPINAL CORD; TETRODOTOXIN; TIME FACTORS;

EID: 72049128878     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2009.09.003     Document Type: Article

References (43)

1. Aubel B., Kayser V., Farré A., Hamon M., and Bourgoin S. Evidence for adenosine- and serotonin-mediated antihyperalgesic effects of cizolirtine in rats suffering from diabetic neuropathy. Neuropharmacology 52 (2007) 487-496
2. Aurilio C., Pota V., Pace M.C., Passavanti M.B., and Barbarisi M. Ionic channels and neuropathic pain: physiopathology and applications. Journal of Cell Physiology 215 (2008) 8-14
3. Bennett G.J., and Xie Y.K. Peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33 (1988) 87-107
4. Bernard J.F., Bester H., and Besson J.M. Involvement of the spino-parabrachio -amygdaloid and -hypothalamic pathways in the autonomic and affective emotional aspects of pain. Progress in Brain Research 107 (1996) 243-255
5. Catheline G., Le Guen S., Honoré P., and Besson J.M. Are there long-term changes in the basal or evoked Fos expression in the dorsal horn of the spinal cord of the mononeuropathic rat?. Pain 80 (1999) 347-357
6. Cesselin F. Opioid and anti-opioid peptides. Fundamental & Clinical Pharmacology 9 (1995) 409-433
7. Christensen D., Idänpään-Heikkilä J.J., Guilbaud G., and Kayser V. The antinociceptive effect of combined systemic administration of morphine and the glycine/NMDA receptor antagonist, (+)-HA966, in a rat model of peripheral neuropathy. British Journal of Pharmacology 125 (1998) 1641-1650
8. Cummins T.R., Sheets P.L., and Waxman S.G. The roles of sodium channels in nociception: implications for mechanisms of pain. Pain 131 (2007) 243-257
9. Davies S.L., Loescher A.R., Clayton N.M., Bountra C., Robinson P.P., and Boissonade F.M. Changes in sodium channel expression following trigeminal nerve injury. Experimental Neurology 202 (2006) 207-216
10. 2+ channels in rats. Journal of Neuroscience Research 86 (2008) 471-479
11. Farmer C.E., Smith K.J., and Docherty R.J. Low concentrations of tetrodotoxin interact with tetrodotoxin-resistant voltage-gated sodium channels. British Journal of Pharmacology 155 (2008) 34-43
12. Finnerup N.B., Otto M., McQuay H.J., Jensen T.S., and Sindrup S.H. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 118 (2005) 289-305
13. Hagen N.A., du Souich P., Lapointe B., Ong-Lam M., Dubuc B., Walde D., Love R., Ngoc A.H., and Canadian Tetrodotoxin Study Group. Tetrodotoxin for moderate to severe cancer pain: a randomized, double blind, parallel design multicenter study. Journal of Pain Symptom Management 35 (2008) 420-429
14. Hains B.C., Saab C.Y., Klein J.P., Craner M.J., and Waxman S.G. Altered sodium channel expression in second-order spinal sensory neurons contributes to pain after peripheral nerve injury. Journal of Neuroscience 24 (2004) 4832-4839
15. Herrero J.F., and Solano R.E. The antinociceptive effect of the mu-opioid fentanyl is reduced in the presence of the alpha(2)-adrenergic antagonist idazoxan in inflammation. Brain Research 840 (1999) 106-114
16. Hirata H., and Aston-Jones G.A. Novel long-latency response of locus coeruleus neurons to noxious stimuli: mediation by peripheral C-fibers. Journal of Neurophysiology 71 (1994) 1752-1761
17. Idänpään-Heikkilä J.J., Guilbaud G., and Kayser V. Prevention of tolerance to the antinociceptive effects of systemic morphine by a selective CCK-B receptor antagonist in a rat model of peripheral neuropathy. Journal of Pharmacology and Experimental Therapeutics 282 (1997) 1366-1372
18. Idänpään-Heikkilä J.J., and Guilbaud G. Pharmacological studies on a rat model of trigeminal neuropathic pain: baclofen, but not carbamazepine, morphine or tricyclic antidepressants, attenuates the allodynia-like behaviour. Pain 79 (1999) 281-290
19. Jain K.K. Current challenges and future prospects in management of neuropathic pain. Expert Reviews in Neurotherapy 8 (2008) 1743-1756
20. 1B/1D receptor agonists, sumatriptan, zolmitriptan and dihydroergotamine, attenuate pain-related behaviour in a rat model of trigeminal neuropathic pain. British Journal of Pharmacology 137 (2002) 1287-1297
21. Kayser V., Desmeules J., and Guilbaud G. Systemic clonidine differentially modulates the abnormal reactions to mechanical and thermal stimuli in rats with peripheral mononeuropathy. Pain 60 (1995) 275-285
22. Kayser V., Elfassi I.E., Aubel B., Melfort M., Julius D., Gingrich J.A., Hamon M., and Bourgoin S. Mechanical, thermal and formalin-induced nociception is differentially altered in 5-HT1A-/-, 5-HT1B-/-, 5-HT2A-/-, 5-HT3A-/- and 5-HTT-/- knock-out male mice. Pain 130 (2007) 235-248
23. King T., Gardell L.R., Wang R., Vardanyan A., Ossipov M.H., Malan Jr. T.P., Vanderah T.W., Hunt S.P., Hruby V.J., Lai J., and Porreca F. Role of NK-1 neurotransmission in opioid-induced hyperalgesia. Pain 116 (2005) 276-288
24. Lantéri-Minet M., Weil-Fugazza J., de Pommery J., and Ménetrey D. Hindbrain structures involved in pain processing as revealed by the expression of c-Fos and other immediate early gene proteins. Neuroscience 58 (1994) 287-298
25. Latrémolière A., Mauborgne A., Masson J., Bourgoin S., Kayser V., Hamon M., and Pohl M. Differential implication of proinflammatory cytokine interleukin-6 in the development of cephalic versus extracephalic neuropathic pain in rats. Journal of Neuroscience 28 (2008) 8489-8501
26. Le Bars D., Gozariu M., and Cadden S.W. Animal models of nociception. Pharmacological Reviews 53 (2001) 597-652
27. Marcil J., Walczak J.S., Guindon J., Ngoc A.H., Lu S., and Beaulieu P. Antinociceptive effects of tetrodotoxin (TTX) in rodents. British Journal of Anaesthesiology 96 (2006) 761-768
28. Martinez V., Christensen D., and Kayser V. The glycine/NMDA receptor antagonist (+)-HA966 enhances the peripheral effect of morphine in neuropathic rats. Pain 99 (2002) 537-545
29. Millan M.J. Descending control of pain. Progress in Neurobiology 66 (2002) 355-474
30. Molander C., Xu Q., and Grant G. The cytoarchitectonic organization of the spinal cord in the rat. The lower thoracic and lumbosacral cord. Journal of Comparative Neurology 230 (1984) 133-141
31. Morgan M.M., Sohn J.H., Lohof A.M., Ben-Eliyahu S., and Liebeskind J.C. Characterization of stimulation-produced analgesia from the nucleus tractus solitarius in the rat. Brain Research 486 (1989) 175-180
32. Nassar M.A., Baker M.D., Levato A., Ingram R., Mallucci G., McMahon S.B., and Wood J.N. Nerve injury induces robust allodynia and ectopic discharges in Nav1.3 null mutant mice. Molecular Pain 2 (2006) 33
33. Nieto F.R., Entrena J.M., Cendàn C.M., Pozo E.D., Vela J.M., and Baeyens J.M. Tetrodotoxin inhibits the development and expression of neuropathic pain induced by paclitaxel in mice. Pain 137 (2008) 520-531
34. Omana-Zapata I., Khabbaz M.A., Hunter J.C., Clarke D.E., and Bley K.R. Tetrodotoxin inhibits neuropathic ectopic activity in neuromas, dorsal root ganglia and dorsal horn neurons. Pain 72 (1997) 41-49
35. Paxinos P., and Watson C. The Rat Brain in Stereotaxic Coordinates (2005), Academic Press, London
36. Randall L.O., and Selitto J.J. A method for measurement of analgesic activity on inflamed tissue. Archives Internationales de Pharmacodynamie et de Thérapie 111 (1957) 409-419
37. Rogers M., Tang L., Madge D.J., and Stevens E.B. The role of sodium channels in neuropathic pain. Seminars in Cellular and Developmental Biology 17 (2006) 571-581
38. Sakurada T., Komatsu T., and Sakurada S. Mechanisms of nociception evoked by intrathecal high-dose morphine. Neurotoxicology 26 (2005) 801-809
39. 3 receptors in the defense reaction-induced inhibition of the aortic baroreflex in rats. Journal of Neurophysiology 90 (2003) 2521-2530
40. Terashvili M., Wu H.-E., Schwasinger E., and Tseng L.F. Paradoxical hyperalgesia induced by mu-opioid receptor agonist endomorphin-2, but not endomorphin-1, microinjected into the centromedial amygdala of the rat. European Journal of Pharmacology 554 (2007) 137-144
41. Vos B.P., Strassman A.M., and Maciewitz R.J. Behavioural evidence of trigeminal neuropathic pain following chronic constriction injury to rat's infraorbital nerve. Journal of Neuroscience 14 (1994) 2708-2723
42. Yokogawa F., Kiuchi Y., Ishikawa Y., Otsuka N., Masuda Y., Ogushi K., and Hosoyamada A. An investigation of monoamine receptors involved in antinociceptive effects of antidepressants. Anesthesiology and Analgesia 95 (2002) 163-168
43. Zhao P., Waxman S.G., and Hains B.C. Sodium channel expression in the ventral posterolateral nucleus of the thalamus after peripheral nerve injury. Molecular Pain 2 (2006) 27